Responses
Clinical Genetics
Posters MG-100 to MG-119
MG-110 Intravenous neonatal gene therapy corrects GM2 gangliosidoses in sandhoff mice for ‘long-term’, by using an aav expressing a new hexosaminidase variant
Compose a Response to This Article
Other responses
No responses have been published for this article.